Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · California
Polypeptide Laboratories
Torrance, CA · ~167 workers · 5 years of OSHA Injury Tracking Application data.
- D
- Poor Safety Record
- 4.6
- Avg TCR
- 3.3
- Industry avg
- 0
- Fatalities
The verdict
Polypeptide Laboratories runs at 138% of its industry's injury rate - more dangerous than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade D.
Polypeptide Laboratories: 4.6 TCR = 138% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 5y Form 300A (see methodology below)
Polypeptide Laboratories safety composite
Polypeptide Laboratories scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on total case rate (tcr) (safer than 15%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).
24/100
Percentile-weighted across 3 of 3 measures
- Total Case Rate (TCR)
- F 4.57 per 100 workers
Safer than 15% of industry peers
- DART rate
- F 2.84 per 100 workers
Safer than 17% of industry peers
- Fatalities
- D 0
Safer than 50% of industry peers
Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).
TCR Δ
−0.7
2017→2024
Polypeptide Laboratories injury rate improved
Polypeptide Laboratories's TCR fell 0.7 from 4.1 in 2017 to 3.4 in 2024. Peak filing year was 2019 at 7.3 TCR. In 2024, DART was 0.62× this establishment's average TCR (severity share of cases).
2017=4.1 · 2019=7.3 · 2021=4.9 · 2023=3.1 · 2024=3.4
OSHA ITA Form 300A scorecard
Establishment book 325412 · Torrance, CA ABOVE-IND · MID
Grade D · TCR 4.6 · 138% of ind
- DART 2.8 DART
- RANK #53/79
- PHOTO Macrocap Labs
- BOOK 5y book
- INJ 28 inj
- SIZE ~167 FTE
Nearest TCR peer: Macrocap Labs (0.0 TCR gap)
Read with this employer → · Industry book → · California employers → · Look up another →
Polypeptide Laboratories in the TCR neighbourhood
Average Total Case Rate among this establishment and nearest same-industry peers
- This site
Polypeptide Laboratories
4.6 TCR
- Macrocap Labs
Macrocap Labs
4.6 TCR
- Dhaliwal Labor
Dhaliwal Laboratories, LLC
4.6 TCR
- Novartis Pharm
Novartis Pharmaceutical Sales Force
4.5 TCR
- UniWell Labora
UniWell Laboratories, LLC (Sovereign Rd)
4.5 TCR
What this shows Polypeptide Laboratories averages 4.6 TCR (138% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).
Polypeptide Laboratories TCR series: 2017=4.1 · 2019=7.3 · 2021=4.9 · 2023=3.1 · 2024=3.4 · BLS 3.3
Where Polypeptide Laboratories falls in its industry
855 Pharmaceutical preparations (e establishmentsSafer than 15% of graded establishments in this industry, whose median TCR is 1.6.
Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #53 safest of 79 Pharmaceutical preparations (e employers in California.
Polypeptide Laboratories has fewer employees than the Pharmaceutical preparations (e.g., capsu median and a higher injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 3.4 | 2.8 | 6 | 0 | 0 |
| 2023 | 3.1 | 2.5 | 5 | 0 | 0 |
| 2021 | 4.9 | 1.2 | 5 | 3 | 0 |
| 2019 | 7.3 | 2.6 | 8 | 3 | 0 |
| 2017 | 4.1 | 1.0 | 4 | 0 | 0 |
OSHA ITA peer cross-reference
Establishment peer ledger
325412 · CA · Torrance
855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 332 employers in Torrance, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.
| Rel | Establishment | Metric |
|---|---|---|
| NAICS-TCR | Macrocap Labs | 4.6 TCR |
| NAICS-TCR | Novartis Pharmaceutical Sales Force | 4.5 TCR |
| NAICS-TCR | UniWell Laboratories, LLC (Sovereign Rd) | 4.5 TCR |
| NAICS-TCR | Dhaliwal Laboratories, LLC | 4.6 TCR |
| STATE-SIZE | C2F Employment Inc. | 167 FTE |
| STATE-SIZE | FIGUEROA PLAZA | 167 FTE |
| STATE-SIZE | Corporate | 167 FTE |
| STATE-SIZE | NA-US-CA-San Jose-2711 N 1st St | 167 FTE |
| CITY-NEAR | Harbor-UCLA Medical Center | 4,144 FTE |
| CITY-NEAR | Torrance Memorial Medical Center | 3,808 FTE |
| CITY-NEAR | Los Angeles | 3,229 FTE |
| CITY-NEAR | California Department of Transportation Facility 494 | 2,621 FTE |
| NAT-TCR | Kelleher Construction, Inc | 4.6 TCR |
| NAT-TCR | Mountain Vista Medical Center | 4.6 TCR |
| NAT-TCR | James E John Construction Co., Inc. | 4.6 TCR |
| NAT-TCR | Master Boat Builders | 4.6 TCR |
| NAT-SIZE | Reily Foods Company - Jfg | 167 FTE |
| NAT-SIZE | Kanzaki Specialty Papers | 167 FTE |
| NAT-SIZE | Kyocera International Inc. | 167 FTE |
| NAT-SIZE | Concordia at Rebecca Residence | 167 FTE |
Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →
Read our methodology - how this data is sourced, computed, and verified.